MMF Immunosuppression Clinical Trials
4 recruitingDrug
Early Phase 13
Showing 1–4 of 4 trials
Recruiting
Double Immunosuppression With or Without Anti-fibrotic in Scleroderma ILD
SSc-Systemic Sclerosis
University of Patras35 enrolled1 locationNCT07491523
Recruiting
Early Phase 1
Universal CAR-T Cells (REVO-UWD-00B) for Refractory and Relapsed Multiple Myeloma
Multiple MyleomaRefractory and Relapsed Multiple Myeloma
Wondercel Biotech (ShenZhen)30 enrolled1 locationNCT06663046
Recruiting
Early Phase 1
Universal CAR-T Cells (REVO-UWD-19) for Refractory and Relapsed B-Cell Tumors
Wondercel Biotech (ShenZhen)30 enrolled1 locationNCT06662227
Recruiting
Early Phase 1
Universal CAR-T Cells (REVO-UWD-03) for Advanced Hepatocellular Carcinoma and Lung Cancer
NSCLC (Advanced Non-small Cell Lung Cancer)HCC - Hepatocellular Carcinoma
Wondercel Biotech (ShenZhen)60 enrolled2 locationsNCT06653023